blocking c-met and braf pathways in melanoma to overcome resistance in mouse models
Published 7 years ago • 114 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
4:07
understanding resistance to combined braf and mek inhibiton in melanoma and the significance of cdk4
-
1:48
using mouse models to develop drugs targeting resistance mechanisms in melanoma
-
2:01
what's next in melanoma research on drug resistance?
-
2:58
role of braf mutation in the treatment for melanoma
-
2:29
braf mutated melanoma: targeted or immunotherapy?
-
47:45
resistance in braf and kras mutant cancers - by ryan corcoran, md, phd
-
6:22
braf and mek in melanoma
-
2:40
neoadjuvant targeted therapy in braf v600 mutated melanoma
-
22:44
braf targeted therapy - melanoma education symposium, peter boasberg md
-
0:48
targeting c/ebpβ in melanoma
-
13:55
mechanisms of pd1 resistance in melanoma and the combinatorial approach to therapies | adib daud, md
-
9:49
melanoma: nuances of braf/mek combinations in the front line
-
24:25
braf inhibition in melanoma tailoring the therapy to the tumor
-
1:11
chemotherapy for melanoma - why is it not effective and what is its future?
-
0:50
causes of increased incidence of melanoma video
-
8:42
melanoma: mechanisms of resistance to therapy
-
0:52
dr. kudchadkar on combining braf and mek inhibitors to treat melanoma
-
1:11
dr. flaherty on resistance in braf-mutant melanoma
-
8:11
understanding response and resistance to cancer therapy: lessons learned from melanoma